Top Markets
Coin of the day
Regent Pacific Group Limited Regent Pacific Group Limited

Regent Pacific Group Limited

0575
株式のランク #27223
Endurance RP Limited functions as an investment holding company, concentrating... Endurance RP Limited functions as an investment holding company, concentrating its investments within the healthcare and life sciences sectors across the People's Republic of China, Europe, Hong Kong, and Taiwan. The firm organizes its activities into two primary divisions: Biopharma and Corporate Investment. The Biopharma segment is responsible for the research, development, production, promotion, and distribution of pharmaceutical products aimed at addressing and managing urological disorders. This division also innovates artificial intelligence systems to precisely track the pace of aging, examining it at molecular, cellular, tissue, organ, systemic, physiological, and psychological levels. Through its Corporate Investment division, the company strategically invests in both publicly traded and privately held corporate entities. Additionally, it extends its services to include management consulting and corporate financial advice. Incorporated in 1991 and headquartered in Central, Hong Kong, Endurance RP Limited adopted its current name in June 2021, having previously operated as Regent Pacific Group Limited.
株価
$0.11769213
最終同期: 2026-07-30
時価総額
$34.34M
変化(1日)
0.00%
変化(1年)
9.45%
HK
取引 Regent Pacific Group Limited (0575)

カテゴリー

Regent Pacific Group Limited(0575)の収益
Aug 2026 時点の収益 TTM: 0
Regent Pacific Group Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Regent Pacific Group Limited の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$27.30B -
US
$16.04B -
US
- -
SE
$21.12B -
US
$5.40B -
US